These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24946270)

  • 1. Combinatorial anticancer effects of curcumin and 5-fluorouracil loaded thiolated chitosan nanoparticles towards colon cancer treatment.
    Anitha A; Deepa N; Chennazhi KP; Lakshmanan VK; Jayakumar R
    Biochim Biophys Acta; 2014 Sep; 1840(9):2730-43. PubMed ID: 24946270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing therapeutic efficacy: sustained delivery of 5-fluorouracil (5-FU) via thiolated chitosan nanoparticles targeting CD44 in triple-negative breast cancer.
    Anjum S; Naseer F; Ahmad T; Jahan F; Qadir H; Gul R; Kousar K; Sarwar A; Shabbir A
    Sci Rep; 2024 May; 14(1):11431. PubMed ID: 38763930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization and
    Al-Nasrawi H; Shalan N; Abualsoud BM; Nsairat H
    Ther Deliv; 2024 Mar; 15(5):339-53. PubMed ID: 38469691
    [No Abstract]   [Full Text] [Related]  

  • 4. CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach.
    Kousar K; Naseer F; Abduh MS; Anjum S; Ahmad T
    Front Immunol; 2023; 14():1175535. PubMed ID: 37283735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH-sensitive docetaxel-loaded chitosan/thiolated hyaluronic acid polymeric nanoparticles for colorectal cancer.
    Noreen S; Pervaiz F; Ijaz M; Hanif MF; Hamza JR; Mahmood H; Shoukat H; Maqbool I; Ashraf MA
    Nanomedicine (Lond); 2024 Apr; 19(9):755-777. PubMed ID: 38334078
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of chitosan-coated flexible liposomes as a remarkable carrier to enhance the antitumor efficacy of 5-fluorouracil against colorectal cancer.
    Alomrani A; Badran M; Harisa GI; ALshehry M; Alhariri M; Alshamsan A; Alkholief M
    Saudi Pharm J; 2019 Jul; 27(5):603-611. PubMed ID: 31297013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterisation of a nucleotide based pro-drug formulated with a peptide into a nano-chemotherapy for colorectal cancer.
    Wilson JJ; Bennie L; Eguaogie O; Elkashif A; Conlon PF; Jena L; McErlean E; Buckley N; Englert K; Dunne NJ; Tucker JHR; Vyle JS; McCarthy HO
    J Control Release; 2024 May; 369():63-74. PubMed ID: 38513729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced brain targeting efficiency using 5-FU (fluorouracil) lipid-drug conjugated nanoparticles in brain cancer therapy.
    Shinde G; Shiyani S; Shelke S; Chouthe R; Kulkarni D; Marvaniya K
    Prog Biomater; 2020 Dec; 9(4):259-275. PubMed ID: 33252721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity of 5-fluorouracil-loaded pH-sensitive liposomal nanoparticles in colorectal cancer cell lines.
    Udofot O; Affram K; Israel B; Agyare E
    Integr Cancer Sci Ther; 2015; 2(5):245-252. PubMed ID: 26691592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the anticancer effects exerted by 5-fluorouracil and heme oxygenase-1 inhibitor hybrids in HTC116 colorectal cancer cells.
    Salerno L; Notaro A; Consoli V; Affranchi F; Pittalà V; Sorrenti V; Vanella L; Giuliano M; Intagliata S
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2337191. PubMed ID: 38634597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transporter targeted-carnitine modified pectin-chitosan nanoparticles for inositol hexaphosphate delivery to the colon: An in silico and in vitro approach.
    Mishra N; Sharma M; Mishra P; Nisha R; Singh P; Pal RR; Singh N; Singh S; Maurya P; Pant S; Mishra PR; Saraf SA
    Int J Biol Macromol; 2024 Apr; 263(Pt 2):130517. PubMed ID: 38423444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Evaluation of Gelatin-Chitosan Biofilms Incorporating Zinc Oxide Nanoparticles and 5-Fluorouracil for Cancer Treatment.
    Kaliyaperumal V; Rajasekaran S; Kanniah R; Gopal D; Ayyakannu Sundaram G; Kumar ASK
    Materials (Basel); 2024 Jun; 17(13):. PubMed ID: 38998269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of 5-fluorouracil induced resistance and role of piperine and curcumin as chemo-sensitizers in colon cancer.
    Bhattacharjya D; Sivalingam N
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; ():. PubMed ID: 38878089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of a Controlled 5-FU Delivery Based on FZD10 Antibody-Conjugated Liposomes in Colorectal Cancer In vitro Models.
    Scavo MP; Cutrignelli A; Depalo N; Fanizza E; Laquintana V; Gasparini G; Giannelli G; Denora N
    Pharmaceutics; 2020 Jul; 12(7):. PubMed ID: 32664186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Colon Cancer Cells with Enzyme-Triggered Casein-Gated Release of Cargo from Mesoporous Silica-Based Nanoparticles.
    Wijewantha N; Eikanger MM; Antony RM; Potts RA; Rezvani K; Sereda G
    Bioconjug Chem; 2021 Nov; 32(11):2353-2365. PubMed ID: 34672618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zebrafish as a Model for Anticancer Nanomedicine Studies.
    Al-Thani HF; Shurbaji S; Yalcin HC
    Pharmaceuticals (Basel); 2021 Jun; 14(7):. PubMed ID: 34203407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer Analysis of CD44 Targeted Cyclosporine Loaded Thiolated Chitosan Nanoformulations for Sustained Release in Triple-Negative Breast Cancer [Retraction].
    Int J Nanomedicine; 2024; 19():5705-5706. PubMed ID: 38895152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Self-degradable Curcumin Polymer with Anti-cancer Activity.
    O'Connor NA; Einbond LS; Redenti S; Sauane M; Jitianu A
    J Appl Polym Sci; 2018 Dec; 135(47):. PubMed ID: 30555179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retraction notice to "Lipid poly (ɛ-caprolactone) hybrid nanoparticles of 5-fluorouracil for sustained release and enhanced anticancer efficacy" [Life Sci. 284 (2021) 119909].
    Khan S; Aamir MN; Madni A; Jan N; Khan A; Jabar A; Shah H; Rahim MA; Ali A
    Life Sci; 2024 Jul; ():122887. PubMed ID: 38972810
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to - Chitosan modified 5-fluorouracil nanostructured lipid carriers for treatment of diabetic retinopathy in rats: A new dimension to an anticancer drug, Vol. 224, 1 January 2023, Pages 810-830.
    Sharma DS; Wadhwa S; Gulati M; Kumar B; Chitranshi N; Gupta VK; Alrouji M; Alhajlah S; AlOmeir O; Vishwas S; Khursheed R; Saini S; Kumar A; Parveen SR; Gupta G; Zacconi F; Chellappan DK; Morris A; Loebenberg R; Dua K; Singh SK
    Int J Biol Macromol; 2024 Apr; 265(Pt 2):131069. PubMed ID: 38552592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.